Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy

NCT03575130 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Fuchs' Endothelial Dystrophy
Fuchs Dystrophy
Corneal Endothelial Dystrophy
Corneal Endothelial Cell Loss
Cornea Guttata

Interventions

DRUG: Ripasudil eye drops
DRUG: Optive eye drops
PROCEDURE: Descemetorhexis

Sponsor

University of Erlangen-Nürnberg Medical School